A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Clinical trial NCT06758557 · RECRUITING
Trial details
- NCT number
- NCT06758557
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-31
- Primary completion
- 2025-10-31
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.